(Code number 04/2020)
At the Max Planck Institute for Medical Research, one of the 86 institutes of the Max Planck Society for the Advancement of Science, physicists, chemists and biologists create knowledge of long-term relevance to life and basic medical sciences.
A postdoctoral position is available at the Department of Chemical Biology (Prof. Kai Johnsson, https://www.mr.mpg.de/13943495/chemical_biology ) of the Max Planck Institute for Medical Research in Heidelberg. The applicant will join an international team to develop new drugs for the treatment of neuropathic pain. The successful candidate will be responsible for the design and synthesis of new lead compounds and their evaluation in various cellular assays.
Applicants should have experiences in medicinal chemistry and chemical biology.
Informal inquiries can be sent to firstname.lastname@example.org
For general questions, please contact Ms. Sabrina Giacalone (+49 6221 486- 305) from human resources.
The Max Planck Society is committed to increasing the number of individuals with disabilities in its workforce and therefore encourages applications from such qualiﬁed individuals.
The Max Planck Society strives for gender and diversity equality. We welcome applications from all backgrounds.
A daycare center for children is located near the institute.
Applicants should send a CV, a Cover Letter briefly summarizing previous research and the addresses of at least two references via e-mail as a single PDF file with the above reference number to email@example.com until 12th April 2020.
Max Planck Institute for Medical Research
C/O Human Resources
POB 10 38 20
69028 Heidelberg, Germany
|Titel||Postdoctoral Position in Drug Development (m/f/d)|
|Employer||Max Planck Institute for Medical Research|
|Job location||Jahnstraße 29, D-69120 Heidelberg|
|Veröffentlicht||Februar 26, 2020|
|Bewerbungsschluss||April 12, 2020|
|Jobart||Post Doc  |
|Fachbereiche||Medizinische Chemie,   Chemische Biologie,   Pharmazie und Pharmakologie  |